Abeona Therapeutics (ABEO) Misses Q2 EPS by 4c

Abeona Therapeutics (NASDAQ: ABEO) reported Q2 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $214 thousand versus the consensus estimate of $240 thousand.

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Chip stocks hit record 19.7% of S&P 500, quadrupling since 2020
• Quarterhill to buy Conduent tolling unit for cash and stock